University Of Waterloo
Waterloo, Ontario, N2L 3G1, Canada
NCT Number: NCT03684928
The aim of this study is to evaluate the subjective acceptance of Comfilcon A contact lenses when worn on a daily wear modality over one month.
Looking for future studies?
Notify Me17 year and older
All sexes
Interventional
Not applicable
Waterloo, Ontario, N2L 3G1, Canada
This study is a 30-subjects prospective, double-masked (investigator and participant), bilateral, randomized, one month cross-over dispensing study comparing subject acceptance of Comfilcon A against Senofilcon A contact lenses.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A person is eligible for inclusion in the study if he/she:
Exclusion criteria
A person will be excluded from the study if he/she:
Daily wear contact lenses
Daily wear contact lenses
Time frame: Baseline
Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)
Time frame: 2 weeks
Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)
Time frame: 1 month
Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)
Time frame: Baseline
Lens relocation after 10 blinks, after 30º rotation mislocation
Time frame: 1 month
Lens relocation after 10 blinks, after 30º rotation mislocation.
CooperVision, Inc.
Industry
A Bilateral Dispensing Comparison of Biofinity Toric and Acuvue Vita for Astigmatism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06751225
Astigmatism Bilateral
Columbus, Ohio, United States
View Trial DetailsNCT05580575
Astigmatism, Astigmatism Bilateral
Medina, Minnesota, United States
View Trial DetailsNCT04297969
Accommodation Disorder, Amblyopia Bilateral
Anchorage, Alaska, United States
View Trial DetailsNCT03779503
Astigmatism Bilateral
Pleasanton, California, United States
View Trial Details